Mird237 Page

Phase 0 toxicology studies are reportedly underway in a non-human primate model. If results are positive, an Investigational New Drug (IND) application could be filed by late 2026, potentially leading to human clinical trials for rotator cuff injuries.

It is important to reiterate that is not a medicine. However, legitimate research uses include: mird237

⭐️⭐️⭐️⭐️⭐️ (5/5)

Hi everyone,

No. MIRD237 is a peptide, not a hormone. It does not bind to androgen receptors nor does it affect testosterone production. Phase 0 toxicology studies are reportedly underway in